Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

Chronic stress may trigger hidden inflammation that damages the heart (opens in a new tab)

medicalxpress.com · 2026-09-18

Short answerEvidenceSource

Short answer

Mostly not supported

Mostly not supported.

2 claims go further than the study. 3 other points were not covered by the paper.

  • 2 supported
  • 2 overstated
  • 3 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mostly not supported

Two of seven claims overstate the study. Two of seven check out. Three claims the study doesn't address.

  • 2 supported
  • 2 overstated
  • 3 not covered
Open claim evidence
3
Source paper

Source layer

The paper behind the story

The source record for this check.

The research anchor for the report.

Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

7 claims in this story

Showing all 7 claimsChoose a verdict to focus the list.

Claim 1 of 7OverstatedChronic stress from everyday life may be causing lasting structural changes to the heart, harming health and reducing life expectancy.View evidenceHide evidence

Why this verdict

The abstract-level profile supports associations among psychosocial/socioeconomic factors, GlycA inflammation, cardiac remodeling, and MACE risk, but not a demonstrated causal chain from everyday chronic stress to lasting heart structural damage, reduced health, or reduced life expectancy. Even though the headline is hedged with 'may,' it outruns the observational evidence and the story body’s caveats about association rather than causation.

1

Study evidence

Higher GlycA is cross-sectionally associated with a restrictive cardiac remodeling pattern: lower indexed LV end-diastolic volume and stroke volume and higher resting heart rate.LV indexed end-diastolic volume β = –2.09; stroke volume β = –1.12; heart rate β = 1.38 (all P < 10^-228)

“We analyzed subsets of 488,079 UK Biobank participants with metabolomic and proteomic profiling, cardiac magnetic resonance (CMR) imaging”
2

Study evidence

Participants in the highest GlycA quintile had higher incidence of major adverse cardiovascular events compared with those in the lowest quintile (adjusted HR 1.43; 95% CI 1.38–1.49).HR 1.43 (95% CI 1.38–1.49)

“Cox models evaluated GlycA levels and major adverse cardiovascular events (MACE).”
Claim 2 of 7OverstatedHigher inflammation was strongly associated with socioeconomic disadvantage, psychological distress, smoking, and excess body fat, and the researchers say some inflammatory proteins from the interleukin-1 and TNF families may be key drivers of the damage.View evidenceHide evidence

Why this verdict

The exposome claim is partly supported: trunk fat mass, current smoking, psychological distress, and low socioeconomic status were among strong determinants of GlycA. But the claim that inflammatory proteins from the IL-1 and TNF families may be 'key drivers of the damage' is stronger and broader than the abstract profile supports. The profile specifically reports observational mediation for IL-1 receptor antagonist and does not verify TNF-family drivers or causal damage mechanisms at abstract depth.

1

Study evidence

Mediation analysis testing 80 circulating inflammatory proteins was performed to identify mediators of the association between GlycA and CMR cardiac remodeling phenotypes.

“Mediation analysis tested 80 inflammatory proteins as potential mediators.”
2

Study evidence

Trunk fat mass was identified as one of the strongest positive exposome determinants of GlycA.β = 0.35

“An exposome-wide association study identified environmental determinants of inflammation”
Claim 3 of 7Not coveredThe findings, published in the European Journal of Preventive Cardiology, come from a study of almost half a million adults in the UK, believed to be the largest of its kind, led by researchers at the MRC Laboratory of Medical Sciences and Imperial College London.View evidenceHide evidence

As statedalmost half a million adults

Why this verdict

The profile supports that UK Biobank subsets up to 488,079 participants were analyzed, so 'almost half a million adults' is broadly consistent. However, the supplied abstract-depth profile does not verify the journal, lead institutions, or the quoted claim that it was 'the largest of its kind.'

1

Study evidence

Higher GlycA is cross-sectionally associated with a restrictive cardiac remodeling pattern: lower indexed LV end-diastolic volume and stroke volume and higher resting heart rate.LV indexed end-diastolic volume β = –2.09; stroke volume β = –1.12; heart rate β = 1.38 (all P < 10^-228)

“We analyzed subsets of 488,079 UK Biobank participants with metabolomic and proteomic profiling, cardiac magnetic resonance (CMR) imaging”
2

Study evidence

Participants in the highest GlycA quintile had higher incidence of major adverse cardiovascular events compared with those in the lowest quintile (adjusted HR 1.43; 95% CI 1.38–1.49).HR 1.43 (95% CI 1.38–1.49)

“Cox models evaluated GlycA levels and major adverse cardiovascular events (MACE).”
Claim 4 of 7Not coveredThose with higher inflammation also showed more evidence of structural heart changes, including thickened heart walls, smaller heart chambers, and poorer heart filling.View evidenceHide evidence

Why this verdict

The abstract profile supports an association between higher GlycA and restrictive remodeling, specifically reduced indexed LV end-diastolic volume, reduced stroke volume, and increased heart rate. It does not verify the specific claims of thickened heart walls or poorer heart filling at this evidence depth, although 'smaller heart chambers' is directionally consistent with reduced LV end-diastolic volume.

1

Study evidence

Higher GlycA is cross-sectionally associated with a restrictive cardiac remodeling pattern: lower indexed LV end-diastolic volume and stroke volume and higher resting heart rate.LV indexed end-diastolic volume β = –2.09; stroke volume β = –1.12; heart rate β = 1.38 (all P < 10^-228)

“We analyzed subsets of 488,079 UK Biobank participants with metabolomic and proteomic profiling, cardiac magnetic resonance (CMR) imaging”
Claim 5 of 7Not coveredThe article says several of these proteins are already being targeted by drugs in clinical trials, raising hopes that anti-inflammatory treatments could help prevent cardiovascular disease before symptoms appear.View evidenceHide evidence

Why this verdict

The abstract profile includes inflammatory-protein mediation findings, especially IL-1RA, but it does not state that these proteins are already drug targets in clinical trials or provide evidence that anti-inflammatory treatments could prevent cardiovascular disease before symptoms. The treatment/prevention discussion may be contextual or from the full article, but it is not verifiable from the supplied abstract-depth paper profile.

1

Study evidence

Mediation analysis testing 80 circulating inflammatory proteins was performed to identify mediators of the association between GlycA and CMR cardiac remodeling phenotypes.

“Mediation analysis tested 80 inflammatory proteins as potential mediators.”
Claim 6 of 7SupportedChronic inflammation, associated with socioeconomic situation and lifestyles, is linked to damaging structural changes in the heart and a higher risk of heart attacks and stroke.View evidenceHide evidence

As stated43% higher risk of heart attack and stroke

Why this verdict

The abstract profile supports that higher GlycA, used as a marker of chronic systemic inflammation, was associated with restrictive cardiac remodeling and with higher MACE risk, and that low socioeconomic status and lifestyle-related factors such as smoking and trunk fat mass were among strong GlycA determinants. The 43% figure matches the adjusted HR 1.43 for highest versus lowest GlycA quintile, though the abstract profile frames the outcome as MACE rather than spelling out only heart attacks and stroke.

1

Study evidence

Higher GlycA is cross-sectionally associated with a restrictive cardiac remodeling pattern: lower indexed LV end-diastolic volume and stroke volume and higher resting heart rate.LV indexed end-diastolic volume β = –2.09; stroke volume β = –1.12; heart rate β = 1.38 (all P < 10^-228)

“We analyzed subsets of 488,079 UK Biobank participants with metabolomic and proteomic profiling, cardiac magnetic resonance (CMR) imaging”
2

Study evidence

Participants in the highest GlycA quintile had higher incidence of major adverse cardiovascular events compared with those in the lowest quintile (adjusted HR 1.43; 95% CI 1.38–1.49).HR 1.43 (95% CI 1.38–1.49)

“Cox models evaluated GlycA levels and major adverse cardiovascular events (MACE).”
Claim 7 of 7SupportedPeople with the highest levels of inflammation (the top 20%) had a 43% higher risk of heart attack and stroke than those with the lowest levels (the bottom 20%).View evidenceHide evidence

As stated43% higher risk

Why this verdict

The paper profile reports that the highest GlycA quintile had 43% higher MACE risk than the lowest quintile, with adjusted HR 1.43 and 95% CI 1.38–1.49. The top/bottom 20% framing matches quintiles; at abstract depth, the exact MACE component definition is not detailed.

1

Study evidence

Participants in the highest GlycA quintile had higher incidence of major adverse cardiovascular events compared with those in the lowest quintile (adjusted HR 1.43; 95% CI 1.38–1.49).HR 1.43 (95% CI 1.38–1.49)

“Cox models evaluated GlycA levels and major adverse cardiovascular events (MACE).”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • Chronic systemic inflammation was operationalized as GlycA measured by NMR, not direct measurement of everyday stress or inflammation in general.

    The story presents the construct as chronic inflammation and often links it to stressors, but the abstract profile’s core exposure is the biomarker GlycA. This distinction matters because GlycA is a proxy marker, and the story does not clearly reflect that measurement specificity.

    From Cross-sectional association analysis (secondary data); Time-to-event cohort analysis (Cox proportional hazards); Exposom

  • The mediation analysis specifically screened 80 inflammatory proteins and highlighted IL-1 receptor antagonist as mediating 27% of the GlycA effect on LV end-diastolic volume.

    The story mentions IL-1/TNF-family proteins as possible key drivers, but it does not accurately reflect the abstract’s specific mediation result for IL-1RA, its 27% mediated estimate, or the observational assumptions behind causal mediation.

    From secondary_data mediation analysis

  • The study included gene–environment interaction analyses using multi-ancestry polygenic risk scores, with PRS modifying associations among environmental exposures, GlycA, and MACE.

    The presentation mentions genetic susceptibility only generally. It does not substantively reflect the paper’s PRS-based interaction analysis, and the abstract profile also lacks quantitative interaction estimates.

    From Gene–environment interaction analysis using multi-ancestry PRS

  • The abstract does not provide key modeling details such as covariates, exact analytic sample sizes for each analysis, follow-up duration, event counts, missing-data handling, or proportional-hazards diagnostics.

    The story’s caveats cover causality but not these methodological limitations, which affect how precisely the strength and generalizability of the reported associations can be judged from the abstract.

    From Cross-sectional association analysis (secondary data); Time-to-event cohort analysis (Cox proportional hazards); Exposom

4 things the story did carry across
  • Higher GlycA was cross-sectionally associated with restrictive cardiac remodeling on CMR, including reduced LV indexed end-diastolic volume and stroke volume with higher resting heart rate.
  • The cardiac remodeling analysis is cross-sectional and cannot establish temporality, directionality, or causality.
  • Higher GlycA predicted longitudinal MACE risk, with the highest quintile having adjusted HR 1.43 versus the lowest quintile.
  • The exposome-wide analysis identified trunk fat mass, current smoking, psychological distress, and low socioeconomic status as among the strongest determinants of GlycA.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

5

Evidence read

study summary

Lead result

secondary data

1Lead resultsecondary dataQuantify associations between chronic systemic inflammation (GlycA) and cardiac remodeling phenotypes derived from CMR in UK Biobank.Cross-sectional association analysis (secondary data)Expand

In plain English

In UK Biobank participants with NMR-measured glycoprotein acetyls (GlycA) and machine learning–derived CMR phenotypes, higher GlycA (marker of chronic systemic inflammation) was cross-sectionally associated with a pattern of restrictive cardiac remodeling: lower indexed left ventricular end-diastolic volume and stroke volume and higher resting heart rate. Associations were estimated using multivariable linear regression and reported with large effect estimates and extreme statistical significance.

Key findings

  • Higher GlycA is cross-sectionally associated with a restrictive cardiac remodeling pattern: lower indexed LV end-diastolic volume and stroke volume and higher resting heart rate.LV indexed end-diastolic volume β = –2.09; stroke volume β = –1.12; heart rate β = 1.38 (all P < 10^-228)
“We analyzed subsets of 488,079 UK Biobank participants with metabolomic and proteomic profiling, cardiac magnetic resonance (CMR) imaging”
What this piece can’t prove
  • Cross-sectional design limits causal inference and directionality.
  • Abstract does not detail covariates included in multivariable models or the exact analytic sample size for the CMR analyses.
  • Potential for residual confounding and measurement variability in exposure and imaging-derived outcomes.

1 further detail could not be confirmed from the summary.

2secondary dataAssess whether circulating inflammatory proteins (e.g., IL-1 receptor antagonist) mediate the association between GlycA and cardiac remodeling phenotypes.secondary data mediation analysisExpand

In plain English

In a UK Biobank subset with circulating proteomic profiling, the authors performed mediation analyses testing 80 inflammatory proteins to evaluate whether any mediate the association between chronic inflammation (GlycA) and cardiac remodeling measured by CMR. Interleukin-1 receptor antagonist (IL-1RA) was reported to mediate 27% of the GlycA effect on left ventricular indexed end-diastolic volume, with an average causal mediated effect (ACME) of −0.51 (95% CI, −0.53 to −0.64; P < 10−16).

Key findings

  • Mediation analysis testing 80 circulating inflammatory proteins was performed to identify mediators of the association between GlycA and CMR cardiac remodeling phenotypes.
  • Interleukin-1 receptor antagonist (IL-1RA) was reported to mediate part of the association between GlycA and left ventricular indexed end-diastolic volume.Proportion mediated = 27%; ACME = −0.51 (95% CI, −0.53 to −0.64); P < 10−16
“Mediation analysis tested 80 inflammatory proteins as potential mediators.”
What this piece can’t prove
  • Proteomic mediation was limited to the 80 proteins in the panel; other mediators were not assessed.
  • Abstract does not specify sample size for the mediation subset, covariates included in mediation models, or correction for multiple mediator testing.

2 further details could not be confirmed from the summary.

3secondary dataEvaluate whether GlycA predicts longitudinal major adverse cardiovascular events (MACE) risk.Time-to-event cohort analysis (Cox proportional hazards)Expand

In plain English

In a longitudinal analysis of UK Biobank participants with metabolomic/proteomic data and outcome linkage, higher circulating GlycA was associated with increased risk of incident major adverse cardiovascular events (MACE). Cox proportional hazards models comparing GlycA quintiles reported an adjusted hazard ratio of 1.43 (95% CI 1.38–1.49) for MACE for the highest versus lowest GlycA quintile.

Key findings

  • Participants in the highest GlycA quintile had higher incidence of major adverse cardiovascular events compared with those in the lowest quintile (adjusted HR 1.43; 95% CI 1.38–1.49).HR 1.43 (95% CI 1.38–1.49)
“Cox models evaluated GlycA levels and major adverse cardiovascular events (MACE).”
What this piece can’t prove
  • No information in abstract on model covariates or potential residual confounding.
  • Follow-up time, number of events, and incidence rates not reported in abstract, limiting assessment of absolute risk.
  • Methodological details such as proportional hazards diagnostics, missing data handling, and competing risk considerations are not provided.

1 further detail could not be confirmed from the summary.

4secondary dataIdentify environmental (exposome) determinants of chronic inflammation (GlycA) in UK Biobank.Exposome-wide association studyExpand

In plain English

An exposome-wide association study (ExWAS) in UK Biobank scanned environmental exposures to identify determinants of chronic inflammation (GlycA). The largest positive associations reported were trunk fat mass and current smoking, with psychological distress and low socioeconomic status also described among the strongest GlycA determinants (all P < 10^-50).

Key findings

  • Trunk fat mass was identified as one of the strongest positive exposome determinants of GlycA.β = 0.35
  • Current smoking was identified as a strong positive determinant of GlycA.β = 0.39
“An exposome-wide association study identified environmental determinants of inflammation”
What this piece can’t prove
  • Observational exposome-association design; reported associations do not establish causality.
  • Abstract does not provide full exposure definitions, harmonization details, or complete covariate/model specifications.
5secondary dataTest gene–environment interactions (polygenic risk scores modifying exposure→inflammation and/or inflammation→MACE relationships) across ancestries.Gene–environment interaction analysis using multi-ancestry PRSExpand

In plain English

The study used multi-ancestry polygenic risk scores (PRS) to test gene–environment interactions as effect modification of relationships between environmental exposures, systemic inflammation (GlycA), and major adverse cardiovascular events (MACE) in UK Biobank; authors report that cardiovascular PRS modified associations between environmental exposures, inflammation, and MACE, but the abstract provides no interaction effect estimates or PRS construction details.

Key findings

  • Cardiovascular polygenic risk scores modified associations between environmental exposures, inflammation (GlycA), and MACE.
“gene-environment interactions were assessed using multi-ancestry polygenic risk scores.”
What this piece can’t prove
  • Abstract lacks details on how multi-ancestry PRS were derived (variants, weights, training populations) and how ancestry was handled.
  • Abstract does not specify model covariates, whether interactions were tested on multiplicative or additive scales, nor correction for multiple testing.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Crossref, Europe PMC · 15 candidate papers

And 9 more candidates considered.